HLS vs NOX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

54MEDIUM

NOX

NOXOPHARM FPO [NOX]

55MEDIUM

Score Breakdown

HLS NOX
Technical
68
46
Catalyst
87
50
Sentiment
50
50
Fundamental
90
39
Momentum
34
60
Risk Gate
32
46

Key Metrics

HLS Metric NOX
$275.9MMarket Cap$26.1M
4.3MAvg Volume (20d)168K
+10.1%Short InterestN/A
$1.07052-Week High$0.135
$0.30052-Week Low$0.046
+3.2%Daily Change+4.7%
$0.392Reference Price$0.089
-69.3%ROE-343.6%
-12.3%Profit Margin-161.7%

Active Signals

HLS Signals

MACD momentum is picking up steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.2x)
EPS estimates revised upward (+10pts)
Near 52-week low (10% of range)

NOX Signals

MACD momentum is losing steam
Watch out — volume is flowing out even as price holds up. Distribution pattern
Drifting lower — down 6.8% over the last 5 days
Beating the Small Ords index — relative strength of 1.26, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (0.1 quarters)
Moderate P/S ratio (7.7x)
Strong revenue growth (+50%)

Ask Scout AI to compare HLS and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HLS vs NUZ →HLS vs NXN →HLS vs PAR →HLS vs PCK →HLS vs PIQ →
HLS Full Analysis → NOX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).